| Keywords: |
immunohistochemistry; cancer chemotherapy; treatment outcome; disease-free survival; survival analysis; cancer surgery; cancer recurrence; cancer radiotherapy; combined modality therapy; neoadjuvant therapy; follow-up studies; lymph node metastasis; lymph node dissection; diagnostic accuracy; sentinel lymph node biopsy; cancer prevention; neoplasm recurrence, local; mastectomy; radiotherapy; clinical assessment; editorial; algorithms; biopsy; cancer mortality; time factors; risk assessment; axillary lymph node; carcinoma in situ; needle biopsy; tamoxifen; eosin; hematoxylin; neoplasm invasiveness; antineoplastic agents, hormonal; axilla; false negative reactions; histocytochemistry; carcinoma, intraductal, noninfiltrating; breast duct
|
